The stock price of GoodRx Holdings Inc (NASDAQ: GDRX) has jumped by 0.45 compared to previous close of 4.46. Despite this, the company has seen a fall of -1.75% in its stock price over the last five trading days. businesswire.com reported 2025-03-17 that SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately. Aaron will be responsible for the management and financial performance of GoodRx’s Rx Marketplace offering, working with key retail pharmacy, pharmacy benefit manager (PBM), employer, and man.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
GoodRx Holdings Inc (NASDAQ: GDRX) has a higher price-to-earnings ratio of 105.16x compared to its average ratio. GDRX has 36-month beta value of 1.26. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 2 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for GDRX is 88.68M, and currently, short sellers hold a 7.17% ratio of that float. The average trading volume of GDRX on March 19, 2025 was 1.40M shares.
GDRX’s Market Performance
GDRX’s stock has seen a -1.75% decrease for the week, with a -11.11% drop in the past month and a -4.68% fall in the past quarter. The volatility ratio for the week is 4.59%, and the volatility levels for the past 30 days are at 5.91% for GoodRx Holdings Inc The simple moving average for the past 20 days is -5.07% for GDRX’s stock, with a -29.26% simple moving average for the past 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Mizuho repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Mizuho is $5 based on the research report published on December 04, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10. The rating they have provided for GDRX stocks is “Strong Buy” according to the report published on August 09th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 23rd of the previous year.
GDRX Trading at -4.97% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.62% of loss for the given period.
Volatility was left at 5.91%, however, over the last 30 days, the volatility rate increased by 4.59%, as shares sank -11.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.75% lower at present.
During the last 5 trading sessions, GDRX fell by -1.75%, which changed the moving average for the period of 200-days by -37.95% in comparison to the 20-day moving average, which settled at $4.72. In addition, GoodRx Holdings Inc saw -3.66% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Bradley Julie MB, who proposed sale 95,255 shares at the price of $4.95 back on Dec 02 ’24. After this action, Bradley Julie MB now owns shares of GoodRx Holdings Inc, valued at $471,451 using the latest closing price.
Spectrum Equity VII, L.P., the 10% Owner of GoodRx Holdings Inc, sale 10,677 shares at $7.86 during a trade that took place back on Sep 03 ’24, which means that Spectrum Equity VII, L.P. is holding 0 shares at $83,922 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.9 for the gross margin
The net margin for GoodRx Holdings Inc stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 2.21, with 1.10 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 3.24. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 1.5.
Currently, EBITDA for the company is 153.92 million with net debt to EBITDA at -2.56. When we switch over and look at the enterprise to sales, we see a ratio of 1.67. The receivables turnover for the company is 4.93for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.32.
Conclusion
To put it simply, GoodRx Holdings Inc (GDRX) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
